Please login to the form below

Not currently logged in
Email:
Password:

Helsinn Therapeutics names Paul Rittman as CEO

He replaces William Mann, who stepped down on 28 February

Helsinn, a Swiss pharmaceutical group focused on cancer care products, has appointed Paul Rittman as its new chief executive officer.

Rittman, who succeeds William Mann, takes up his new role on 5 March and has pharmaceutical industry experience from previous commercial and general management roles.

Riccardo Bragila, vice chairman and chief executive officer for Helsinn Group, said: “I am delighted to welcome aboard Paul Rittman, who has over 30 years’ experience in pharmaceutical sales and marketing with oncology and across a range of disease areas in North America.

“I am sure his expertise, experience and network will prove invaluable in this key commercial moment for the Helsinn Group.”

Rittman most recently served as senior vice president and general manager, US oncology, leading Teva Pharmaceuticals’ oncology activities for its branded products operations.

Prior to his time at Teva, he also held a number of other senior commercial roles at Intrabiotics and Aventis.

Rittman said: “I have always been impressed with Helsinn’s core values of quality, integrity and respect and so I am delighted to be joining at this time.

“Helsinn is an international pharmaceutical business strongly committed to growth through investing in oncology while working to improve the everyday lives of people with cancer.”

1st March 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics